English

ENTEST BIOMEDICAL, INC.

EDGAR

ETNI Quarterly report (10-Q) · filed 2020-01-21

49 filing records in this dataset, filed from 2009-04-15 to 2020-01-21. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2020 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-17.1 thousand USD

2020 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -17095 USD Source

Cash and cash equivalents: 0 USD 2019-11-30 Source
Exact value

0 USD
Long-term debt including current maturities: Not available
Shares outstanding: 49.2 million shares 2019-11-30 Source
Exact value

49171083 shares

Reported share-count change

0.00% · 611 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

49170472 shares · 2018-11-30· Source
49171083 shares · 2019-11-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-46.4 thousand USD

2018-12-01 – 2019-11-30

Exact inputs and evidence

Net income: -10972 USD · 2018-12-01 – 2019-02-28 Source
Net income: -10642 USD · 2019-03-01 – 2019-05-31 Source
Net income: 191618 USD · 2018-09-01 – 2019-08-31 Source
Net income: 198397 USD · 2018-09-01 – 2019-05-31 Source
Net income: -17992 USD · 2019-09-01 – 2019-11-30 Source

Operating cash flow

-19.2 thousand USD

2018-12-01 – 2019-11-30

Exact inputs and evidence

Operating cash flow: -3959 USD · 2018-09-01 – 2019-02-28 Source
Operating cash flow: -1873 USD · 2018-09-01 – 2018-11-30 Source
Operating cash flow: -3959 USD · 2018-09-01 – 2019-05-31 Source
Operating cash flow: -3959 USD · 2018-09-01 – 2019-02-28 Source
Operating cash flow: -3959 USD · 2018-09-01 – 2019-08-31 Source
Operating cash flow: -3959 USD · 2018-09-01 – 2019-05-31 Source
Operating cash flow: -17095 USD · 2019-09-01 – 2019-11-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-01-21.

Financial data available through: 2019-08-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2019-08-31
Operating income: 11 of 11 periods available· newest 2019-08-31
Net income: 11 of 11 periods available· newest 2019-08-31
Operating cash flow: 11 of 11 periods available· newest 2019-08-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2019-08-31
Total liabilities: 11 of 11 periods available· newest 2019-08-31
Current assets: 11 of 11 periods available· newest 2019-08-31
Current liabilities: 11 of 11 periods available· newest 2019-08-31
Cash and cash equivalents: 11 of 11 periods available· newest 2019-08-31
long term debt: No compatible figures in this window
Shares outstanding: 10 of 11 periods available· newest 2019-08-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2017-09-01 – 2018-08-31
Current period

USD 0

2018-09-01 – 2019-08-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2017-09-01 – 2018-08-31
Inspect prior input Prior source
0 USD · 2018-09-01 – 2019-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ENTEST BIOMEDICAL, INC. · 2019-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#66194 Filing: 000164033419002635 Input fundies:Revenue: 0 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#66058 Filing: 000164033419002635
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.67 million

Prior period

−USD 1.48 million

2017-09-01 – 2018-08-31
Current period

USD 191,618

2018-09-01 – 2019-08-31

Exact inputs and evidence

191618 − -1477484 = 1669102 USD

-1477484 USD · 2017-09-01 – 2018-08-31
Inspect prior input Prior source
191618 USD · 2018-09-01 – 2019-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ENTEST BIOMEDICAL, INC. · 2019-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Year-over-year change in Net income: 1669102 USD Concept: fundies:NetIncome Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 191618 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#70335 Filing: 000164033419002635 Input fundies:NetIncome: -1477484 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#69976 Filing: 000164033419002635
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.49 million

Prior period

−USD 1.49 million

2017-09-01 – 2018-08-31
Current period

−USD 3,959

2018-09-01 – 2019-08-31

Exact inputs and evidence

-3959 − -1490101 = 1486142 USD

-1490101 USD · 2017-09-01 – 2018-08-31
Inspect prior input Prior source
-3959 USD · 2018-09-01 – 2019-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ENTEST BIOMEDICAL, INC. · 2019-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Year-over-year change in Operating cash flow: 1486142 USD Concept: fundies:OperatingCashFlow Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3959 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#85352 Filing: 000164033419002635 Input fundies:OperatingCashFlow: -1490101 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#85141 Filing: 000164033419002635
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2018-09-01 – 2019-08-31

Revenue USD 0
Operating costs Derived USD 40,118
Operating income −USD 40,118
Tax, interest and other Derived −USD 231,736
Net income USD 191,618

Cash

Operating cash flow −USD 3,959
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Not shown: operating income or net income is not reported.
2011 Operating loss: operating costs were 361% of revenue.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2009-09-01 – 2010-08-31	0	537816 Derived	-537816	7075 Derived	-544891	Unavailable	Source 2009-09-01 – 2010-08-31: 0 USD Inspect Revenue Open source 2009-09-01 – 2010-08-31: -537816 USD Inspect Operating Income Open source 2009-09-01 – 2010-08-31: -544891 USD Inspect Net Income Open source 2009-09-01 – 2010-08-31: -221226 USD Inspect Operating Cash Flow Open source
2011 2010-09-01 – 2011-08-31	349141	1260191 Derived	-911050	43348 Derived	-954398	Unavailable	Source 2010-09-01 – 2011-08-31: 349141 USD Inspect Revenue Open source 2010-09-01 – 2011-08-31: -911050 USD Inspect Operating Income Open source 2010-09-01 – 2011-08-31: -954398 USD Inspect Net Income Open source 2010-09-01 – 2011-08-31: -825863 USD Inspect Operating Cash Flow Open source
2012 2011-09-01 – 2012-08-31	0	812382 Derived	-812382	1073442 Derived	-1885824	Unavailable	Source 2011-09-01 – 2012-08-31: 0 USD Inspect Revenue Open source 2011-09-01 – 2012-08-31: -812382 USD Inspect Operating Income Open source 2011-09-01 – 2012-08-31: -1885824 USD Inspect Net Income Open source 2011-09-01 – 2012-08-31: -924009 USD Inspect Operating Cash Flow Open source
2013 2012-09-01 – 2013-08-31	0	662997 Derived	-662997	630586 Derived	-1293583	Unavailable	Source 2012-09-01 – 2013-08-31: 0 USD Inspect Revenue Open source 2012-09-01 – 2013-08-31: -662997 USD Inspect Operating Income Open source 2012-09-01 – 2013-08-31: -1293583 USD Inspect Net Income Open source 2012-09-01 – 2013-08-31: -974603 USD Inspect Operating Cash Flow Open source
2014 2013-09-01 – 2014-08-31	0	380115 Derived	-380115	1036828 Derived	-1416943	Unavailable	Source 2013-09-01 – 2014-08-31: 0 USD Inspect Revenue Open source 2013-09-01 – 2014-08-31: -380115 USD Inspect Operating Income Open source 2013-09-01 – 2014-08-31: -1416943 USD Inspect Net Income Open source 2013-09-01 – 2014-08-31: -1416058 USD Inspect Operating Cash Flow Open source
2015 2014-09-01 – 2015-08-31	0	441121 Derived	-441121	44153 Derived	-485274	Unavailable	Source 2014-09-01 – 2015-08-31: 0 USD Inspect Revenue Open source 2014-09-01 – 2015-08-31: -441121 USD Inspect Operating Income Open source 2014-09-01 – 2015-08-31: -485274 USD Inspect Net Income Open source 2014-09-01 – 2015-08-31: -68674 USD Inspect Operating Cash Flow Open source
2016 2015-09-01 – 2016-08-31	0	538787 Derived	-538787	-32097 Derived	-506690	Unavailable	Source 2015-09-01 – 2016-08-31: 0 USD Inspect Revenue Open source 2015-09-01 – 2016-08-31: -538787 USD Inspect Operating Income Open source 2015-09-01 – 2016-08-31: -506690 USD Inspect Net Income Open source 2015-09-01 – 2016-08-31: -43362 USD Inspect Operating Cash Flow Open source
2017 2016-09-01 – 2017-08-31	0	651879 Derived	-651879	12913 Derived	-664792	Unavailable	Source 2016-09-01 – 2017-08-31: 0 USD Inspect Revenue Open source 2016-09-01 – 2017-08-31: -651879 USD Inspect Operating Income Open source 2016-09-01 – 2017-08-31: -664792 USD Inspect Net Income Open source 2016-09-01 – 2017-08-31: -473380 USD Inspect Operating Cash Flow Open source
2018 2017-09-01 – 2018-08-31	0	1520899 Derived	-1520899	-43415 Derived	-1477484	Unavailable	Source 2017-09-01 – 2018-08-31: 0 USD Inspect Revenue Open source 2017-09-01 – 2018-08-31: -1520899 USD Inspect Operating Income Open source 2017-09-01 – 2018-08-31: -1477484 USD Inspect Net Income Open source 2017-09-01 – 2018-08-31: -1490101 USD Inspect Operating Cash Flow Open source
2019 2018-09-01 – 2019-08-31	0	40118 Derived	-40118	-231736 Derived	191618	Unavailable	Source 2018-09-01 – 2019-08-31: 0 USD Inspect Revenue Open source 2018-09-01 – 2019-08-31: -40118 USD Inspect Operating Income Open source 2018-09-01 – 2019-08-31: 191618 USD Inspect Net Income Open source 2018-09-01 – 2019-08-31: -3959 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-08-31	Revenue	0	Revenue: 0 Open source
20112011-08-31	Revenue	349141	Revenue: 349141 Open source
20122012-08-31	Revenue	0	Revenue: 0 Open source
20132013-08-31	Revenue	0	Revenue: 0 Open source
20142014-08-31	Revenue	0	Revenue: 0 Open source
20152015-08-31	Revenue	0	Revenue: 0 Open source
20162016-08-31	Revenue	0	Revenue: 0 Open source
20172017-08-31	Revenue	0	Revenue: 0 Open source
20182018-08-31	Revenue	0	Revenue: 0 Open source
20192019-08-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20112011-08-31	Year over year	No prior comparable period	Revenue: 349141 Open source Revenue: 0 Open source
20122012-08-31	Year over year	-100%	Revenue: 0 Open source Revenue: 349141 Open source
20132013-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20142014-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20152015-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20162016-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20172017-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -260.9% 2011

Net margin -273.4% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-08-31	Operating margin	Not reported	Operating Income: -537816 Open source Revenue: 0 Open source
20112011-08-31	Operating margin	-260.9%	Operating Income: -911050 Open source Revenue: 349141 Open source
20122012-08-31	Operating margin	Not reported	Operating Income: -812382 Open source Revenue: 0 Open source
20132013-08-31	Operating margin	Not reported	Operating Income: -662997 Open source Revenue: 0 Open source
20142014-08-31	Operating margin	Not reported	Operating Income: -380115 Open source Revenue: 0 Open source
20152015-08-31	Operating margin	Not reported	Operating Income: -441121 Open source Revenue: 0 Open source
20162016-08-31	Operating margin	Not reported	Operating Income: -538787 Open source Revenue: 0 Open source
20172017-08-31	Operating margin	Not reported	Operating Income: -651879 Open source Revenue: 0 Open source
20182018-08-31	Operating margin	Not reported	Operating Income: -1520899 Open source Revenue: 0 Open source
20192019-08-31	Operating margin	Not reported	Operating Income: -40118 Open source Revenue: 0 Open source
20102010-08-31	Net margin	Not reported	Net Income: -544891 Open source Revenue: 0 Open source
20112011-08-31	Net margin	-273.4%	Net Income: -954398 Open source Revenue: 349141 Open source
20122012-08-31	Net margin	Not reported	Net Income: -1885824 Open source Revenue: 0 Open source
20132013-08-31	Net margin	Not reported	Net Income: -1293583 Open source Revenue: 0 Open source
20142014-08-31	Net margin	Not reported	Net Income: -1416943 Open source Revenue: 0 Open source
20152015-08-31	Net margin	Not reported	Net Income: -485274 Open source Revenue: 0 Open source
20162016-08-31	Net margin	Not reported	Net Income: -506690 Open source Revenue: 0 Open source
20172017-08-31	Net margin	Not reported	Net Income: -664792 Open source Revenue: 0 Open source
20182018-08-31	Net margin	Not reported	Net Income: -1477484 Open source Revenue: 0 Open source
20192019-08-31	Net margin	Not reported	Net Income: 191618 Open source Revenue: 0 Open source
20102010-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -221226 Open source
20112011-08-31	Free cash flow margin	Not reported	Revenue: 349141 Open source Operating Cash Flow: -825863 Open source
20122012-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -924009 Open source
20132013-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -974603 Open source
20142014-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1416058 Open source
20152015-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -68674 Open source
20162016-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -43362 Open source
20172017-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -473380 Open source
20182018-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1490101 Open source
20192019-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -3959 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4K 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-08-31	Operating cash flow	-221226	Operating Cash Flow: -221226 Open source
20112011-08-31	Operating cash flow	-825863	Operating Cash Flow: -825863 Open source
20122012-08-31	Operating cash flow	-924009	Operating Cash Flow: -924009 Open source
20132013-08-31	Operating cash flow	-974603	Operating Cash Flow: -974603 Open source
20142014-08-31	Operating cash flow	-1416058	Operating Cash Flow: -1416058 Open source
20152015-08-31	Operating cash flow	-68674	Operating Cash Flow: -68674 Open source
20162016-08-31	Operating cash flow	-43362	Operating Cash Flow: -43362 Open source
20172017-08-31	Operating cash flow	-473380	Operating Cash Flow: -473380 Open source
20182018-08-31	Operating cash flow	-1490101	Operating Cash Flow: -1490101 Open source
20192019-08-31	Operating cash flow	-3959	Operating Cash Flow: -3959 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-08-31	Free cash flow	Unavailable	Operating Cash Flow: -221226 Open source
20112011-08-31	Free cash flow	Unavailable	Operating Cash Flow: -825863 Open source
20122012-08-31	Free cash flow	Unavailable	Operating Cash Flow: -924009 Open source
20132013-08-31	Free cash flow	Unavailable	Operating Cash Flow: -974603 Open source
20142014-08-31	Free cash flow	Unavailable	Operating Cash Flow: -1416058 Open source
20152015-08-31	Free cash flow	Unavailable	Operating Cash Flow: -68674 Open source
20162016-08-31	Free cash flow	Unavailable	Operating Cash Flow: -43362 Open source
20172017-08-31	Free cash flow	Unavailable	Operating Cash Flow: -473380 Open source
20182018-08-31	Free cash flow	Unavailable	Operating Cash Flow: -1490101 Open source
20192019-08-31	Free cash flow	Unavailable	Operating Cash Flow: -3959 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

2,740.1% 2018

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20102010-08-31	Liabilities / assets	358.9%	Total Liabilities: 306003 Open source Total Assets: 85261 Open source
20112011-08-31	Liabilities / assets	69.1%	Total Liabilities: 384254 Open source Total Assets: 555992 Open source
20122012-08-31	Liabilities / assets	111%	Total Liabilities: 585626 Open source Total Assets: 527827 Open source
20132013-08-31	Liabilities / assets	1,355.9%	Total Liabilities: 741572 Open source Total Assets: 54694 Open source
20142014-08-31	Liabilities / assets	6,475.5%	Total Liabilities: 689838 Open source Total Assets: 10653 Open source
20152015-08-31	Liabilities / assets	4,005.8%	Total Liabilities: 807538 Open source Total Assets: 20159 Open source
20162016-08-31	Liabilities / assets	4,202.7%	Total Liabilities: 1002728 Open source Total Assets: 23859 Open source
20172017-08-31	Liabilities / assets	95%	Total Liabilities: 319345 Open source Total Assets: 336169 Open source
20182018-08-31	Liabilities / assets	2,740.1%	Total Liabilities: 255018 Open source Total Assets: 9307 Open source
20192019-08-31	Liabilities / assets	Not reported	Total Liabilities: 32671 Open source Total Assets: 0 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20102010-08-31	Current assets / current liabilities	0.18×	Current Assets: 55802 Open source Current Liabilities: 306003 Open source
20112011-08-31	Current assets / current liabilities	0.4×	Current Assets: 121571 Open source Current Liabilities: 305111 Open source
20122012-08-31	Current assets / current liabilities	0.2×	Current Assets: 111792 Open source Current Liabilities: 549157 Open source
20132013-08-31	Current assets / current liabilities	0.07×	Current Assets: 52505 Open source Current Liabilities: 741572 Open source
20142014-08-31	Current assets / current liabilities	0.01×	Current Assets: 8734 Open source Current Liabilities: 689838 Open source
20152015-08-31	Current assets / current liabilities	0.02×	Current Assets: 20159 Open source Current Liabilities: 807538 Open source
20162016-08-31	Current assets / current liabilities	0.02×	Current Assets: 23859 Open source Current Liabilities: 1002728 Open source
20172017-08-31	Current assets / current liabilities	0.46×	Current Assets: 146119 Open source Current Liabilities: 319345 Open source
20182018-08-31	Current assets / current liabilities	0.04×	Current Assets: 9307 Open source Current Liabilities: 255018 Open source
20192019-08-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 32671 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2009-09-01 – 2010-08-31	−USD 544,891 Exact value Exact value: -544891 USD 2009-09-01 – 2010-08-31: -544891 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2010-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -544891 USD Concept: fundies:NetIncome Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:NetIncome: -544891 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706214000196/entb-20140831.xml#109783 Filing: 000160706214000196 The citation records this snapshot. The page link may show a newer release later.	−USD 221,226 Exact value Exact value: -221226 USD 2009-09-01 – 2010-08-31: -221226 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2010-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -221226 USD Concept: fundies:OperatingCashFlow Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -221226 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000139390512000311/entb-20120229.xml#43927 Filing: 000139390512000311 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2010-09-01 – 2011-08-31	−USD 954,398 Exact value Exact value: -954398 USD 2010-09-01 – 2011-08-31: -954398 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2011-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -954398 USD Concept: fundies:NetIncome Period: 2010-09-01 to 2011-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2011-08-31&surface=latest&period_type=duration&start=2010-09-01&unit=USD&dimensions= Input fundies:NetIncome: -954398 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706214000196/entb-20140831.xml#109909 Filing: 000160706214000196 The citation records this snapshot. The page link may show a newer release later.	−USD 825,863 Exact value Exact value: -825863 USD 2010-09-01 – 2011-08-31: -825863 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2011-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -825863 USD Concept: fundies:OperatingCashFlow Period: 2010-09-01 to 2011-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2011-08-31&surface=latest&period_type=duration&start=2010-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -825863 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000155479513000069/entb-20120831.xml#92012 Filing: 000155479513000069 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2011-09-01 – 2012-08-31	−USD 1.89 million Exact value Exact value: -1885824 USD 2011-09-01 – 2012-08-31: -1885824 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2012-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -1885824 USD Concept: fundies:NetIncome Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1885824 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706214000196/entb-20140831.xml#110035 Filing: 000160706214000196 The citation records this snapshot. The page link may show a newer release later.	−USD 924,009 Exact value Exact value: -924009 USD 2011-09-01 – 2012-08-31: -924009 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2012-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -924009 USD Concept: fundies:OperatingCashFlow Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -924009 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000155479513000746/entb-20130831.xml#111757 Filing: 000155479513000746 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2012-09-01 – 2013-08-31	−USD 1.29 million Exact value Exact value: -1293583 USD 2012-09-01 – 2013-08-31: -1293583 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2013-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -1293583 USD Concept: fundies:NetIncome Period: 2012-09-01 to 2013-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2013-08-31&surface=latest&period_type=duration&start=2012-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1293583 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706214000196/entb-20140831.xml#108181 Filing: 000160706214000196 The citation records this snapshot. The page link may show a newer release later.	−USD 974,603 Exact value Exact value: -974603 USD 2012-09-01 – 2013-08-31: -974603 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2013-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -974603 USD Concept: fundies:OperatingCashFlow Period: 2012-09-01 to 2013-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2013-08-31&surface=latest&period_type=duration&start=2012-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -974603 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706214000196/entb-20140831.xml#167841 Filing: 000160706214000196 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-09-01 – 2014-08-31	−USD 1.42 million Exact value Exact value: -1416943 USD 2013-09-01 – 2014-08-31: -1416943 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2014-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -1416943 USD Concept: fundies:NetIncome Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2014-08-31&surface=latest&period_type=duration&start=2013-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1416943 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706215000525/entb-20150831.xml#74568 Filing: 000160706215000525 The citation records this snapshot. The page link may show a newer release later.	−USD 1.42 million Exact value Exact value: -1416058 USD 2013-09-01 – 2014-08-31: -1416058 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2014-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -1416058 USD Concept: fundies:OperatingCashFlow Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2014-08-31&surface=latest&period_type=duration&start=2013-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1416058 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706215000525/entb-20150831.xml#60394 Filing: 000160706215000525 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-09-01 – 2015-08-31	−USD 485,274 Exact value Exact value: -485274 USD 2014-09-01 – 2015-08-31: -485274 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2015-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -485274 USD Concept: fundies:NetIncome Period: 2014-09-01 to 2015-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2015-08-31&surface=latest&period_type=duration&start=2014-09-01&unit=USD&dimensions= Input fundies:NetIncome: -485274 USD (2014-09-01 to 2015-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706216001077/entb-20160831.xml#68182 Filing: 000160706216001077 The citation records this snapshot. The page link may show a newer release later.	−USD 68,674 Exact value Exact value: -68674 USD 2014-09-01 – 2015-08-31: -68674 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2015-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -68674 USD Concept: fundies:OperatingCashFlow Period: 2014-09-01 to 2015-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2015-08-31&surface=latest&period_type=duration&start=2014-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68674 USD (2014-09-01 to 2015-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706216001077/entb-20160831.xml#71161 Filing: 000160706216001077 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-09-01 – 2016-08-31	−USD 506,690 Exact value Exact value: -506690 USD 2015-09-01 – 2016-08-31: -506690 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2016-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -506690 USD Concept: fundies:NetIncome Period: 2015-09-01 to 2016-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2016-08-31&surface=latest&period_type=duration&start=2015-09-01&unit=USD&dimensions= Input fundies:NetIncome: -506690 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706217000423/entb-20170831.xml#241843 Filing: 000160706217000423 The citation records this snapshot. The page link may show a newer release later.	−USD 43,362 Exact value Exact value: -43362 USD 2015-09-01 – 2016-08-31: -43362 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2016-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -43362 USD Concept: fundies:OperatingCashFlow Period: 2015-09-01 to 2016-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2016-08-31&surface=latest&period_type=duration&start=2015-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43362 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706217000423/entb-20170831.xml#227061 Filing: 000160706217000423 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-09-01 – 2017-08-31	−USD 664,792 Exact value Exact value: -664792 USD 2016-09-01 – 2017-08-31: -664792 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2017-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -664792 USD Concept: fundies:NetIncome Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2017-08-31&surface=latest&period_type=duration&start=2016-09-01&unit=USD&dimensions= Input fundies:NetIncome: -664792 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706218000462/entb-20180831.xml#79170 Filing: 000160706218000462 The citation records this snapshot. The page link may show a newer release later.	−USD 473,380 Exact value Exact value: -473380 USD 2016-09-01 – 2017-08-31: -473380 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2017-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -473380 USD Concept: fundies:OperatingCashFlow Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2017-08-31&surface=latest&period_type=duration&start=2016-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -473380 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000160706218000462/entb-20180831.xml#85397 Filing: 000160706218000462 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2017-09-01 – 2018-08-31	−USD 1.48 million Exact value Exact value: -1477484 USD 2017-09-01 – 2018-08-31: -1477484 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2018-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: -1477484 USD Concept: fundies:NetIncome Period: 2017-09-01 to 2018-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2018-08-31&surface=latest&period_type=duration&start=2017-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1477484 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#69976 Filing: 000164033419002635 The citation records this snapshot. The page link may show a newer release later.	−USD 1.49 million Exact value Exact value: -1490101 USD 2017-09-01 – 2018-08-31: -1490101 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2018-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -1490101 USD Concept: fundies:OperatingCashFlow Period: 2017-09-01 to 2018-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2018-08-31&surface=latest&period_type=duration&start=2017-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1490101 USD (2017-09-01 to 2018-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#85141 Filing: 000164033419002635 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2018-09-01 – 2019-08-31	USD 191,618 Exact value Exact value: 191618 USD 2018-09-01 – 2019-08-31: 191618 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENTEST BIOMEDICAL, INC. · 2019-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Net Income: 191618 USD Concept: fundies:NetIncome Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3ANetIncome&period=2019-08-31&surface=latest&period_type=duration&start=2018-09-01&unit=USD&dimensions= Input fundies:NetIncome: 191618 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#70335 Filing: 000164033419002635 The citation records this snapshot. The page link may show a newer release later.	−USD 3,959 Exact value Exact value: -3959 USD 2018-09-01 – 2019-08-31: -3959 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENTEST BIOMEDICAL, INC. · 2019-08-31 ENTEST BIOMEDICAL, INC. (edgar:1449447) Operating Cash Flow: -3959 USD Concept: fundies:OperatingCashFlow Period: 2018-09-01 to 2019-08-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1449447/explain?concept=fundies%3AOperatingCashFlow&period=2019-08-31&surface=latest&period_type=duration&start=2018-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3959 USD (2018-09-01 to 2019-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1449447/000164033419002635/etni-20190831.xml#85352 Filing: 000164033419002635 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

49 filings · 2,009 latest values · 2,045 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001449447, 1449447, ETNI, edgar:1449447

Also known as ENTEST BIOMEDICAL, INC., ENTEST GROUP, INC., JB Clothing Corp

ENTEST BIOMEDICAL, INC.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2019 2018-09-01 – 2019-08-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation